Validation of the S Classification of Sentinel Lymph Node and Microanatomic Location of Sentinel Lymph Node Metastases to Predict Additional Lymph Node Involvement and Overall Survival in Breast Cancer Patients

[1] Lyman GH(2005)American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 7703-7720

[2] Giuliano AE(2002)Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania Cancer 94 2542-2551

[3] Somerfield MR(2006)Lymphatic mapping and sentinel lymph node biopsy in early-stage breast cancer: a meta-analysis Cancer 106 4-16

[4] Schwartz GF(2000)Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer J Clin Oncol 18 2553-2559

[5] Giuliano AE(2005)Prerandomization surgical training for the NSABP-B32 trial—a randomization phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node negative breast cancer Ann Surg 241 48-54

[6] Veronesi U(2003)A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 546-553

[7] Kim T(1998)The sentinel node in breast cancer—amulticenter validation study N Engl J Med 339 941-946

[8] Giuliano AE(1997)Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Lancet 349 1864-1867

[9] Lyman GH(2006)The prevention, detection, and management of breast cancer Med J Aust 184 230-234

[10] Giuliano AE(2003)Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers J Natl Cancer Inst 95 1514-1521

[1] Lyman GH(2005)American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 7703-7720

[2] Giuliano AE(2002)Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania Cancer 94 2542-2551

[3] Somerfield MR(2006)Lymphatic mapping and sentinel lymph node biopsy in early-stage breast cancer: a meta-analysis Cancer 106 4-16

[4] Schwartz GF(2000)Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer J Clin Oncol 18 2553-2559

[5] Giuliano AE(2005)Prerandomization surgical training for the NSABP-B32 trial—a randomization phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node negative breast cancer Ann Surg 241 48-54

[6] Veronesi U(2003)A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 546-553

[7] Kim T(1998)The sentinel node in breast cancer—amulticenter validation study N Engl J Med 339 941-946

[8] Giuliano AE(1997)Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Lancet 349 1864-1867

[9] Lyman GH(2006)The prevention, detection, and management of breast cancer Med J Aust 184 230-234

[10] Giuliano AE(2003)Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers J Natl Cancer Inst 95 1514-1521